Ignite Creation Date:
2024-05-05 @ 5:11 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00404833
Status:
COMPLETED
Last Update Posted:
2013-10-23
First Post:
2006-11-27
Brief Title:
Mycophenolate Mofetil in Membranous Nephropathy and Focal Segmental
Sponsor:
Hospital Authority Hong Kong
Organization:
Hospital Authority Hong Kong
Study Overview
Official Title:
A Prospective Randomized Open-label Study to Compare Mycophenolate Mofetil and Corticosteroid With Conventional Immunosuppressive Treatment on Proteinuria in Idiopathic Membranous Nephropathy MN and Focal Segmental Glomerulosclerosis FSGS
Status:
COMPLETED
Status Verified Date:
2013-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a prospective randomized open-label pilot study to investigate the effect of mycophenolate mofetil treatment in patients with abnormal urine protein excretion due to membranous nephropathy MN or focal segmental glomerulosclerosis FSGS The change in urine protein excretion will be the primary outcome studied The treatment regimen comprising prednisolone and mycophenolate mofetil will be compared with prednisolone and chlorambucil in MN and compared with prednisolone in FSGS The study duration will be 12 months for each patient
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| HARECCTR0500005 | None | None | None |